Abstract:Objectives To evaluate the initial and long-term clinical outcomes of patients with unprotected left main (ULM) stenosis undergoing percutaneous coronary intervention (PCI) with drug eluting stents (DES) at XiJing Hospital Centre in real world patient population. Methods After excluding acute ST-segment elevation myocardial infarction and bailout stenting, 798 patients treated for ULM disease with DES from January 2003 to December 2011 at XiJing Hospital were enrolled. The clinical outcomes of ULM treated with DES were evaluated by major adverse cardiac events (MACE) and stent thrombosis (ST) during in-hospital period and after long-term follow-up respectively. MACE was defined as cardiac death, non-fatal myocardial infarction (MI) and clinically driven target lesion revascularisation (TLR). ST was evaluated in accordance with the Academic Research Consortium (ARC) definitions. Results The mean age of study population was 62±10 years, 649 (81%) patients were male, 199 (25%) patients were diabetic, and the mean ejection fraction was 54%±11%. 71 (9%) patients had an ostial and 27 (3%) had a shaft lesion (nondistal subgroup), 700 (88%) patients had a bifurcation lesion (distal subgroup). In distal subgroup, 416 (59%) patients were treated with 1 stent (1-stent subgroup) and 284 (41%) were treated with 2 stent (2-stent subgroup). Among 2-stent subgroup, 74 (11%) patients were treated with crush (crush subgroup), 86 (12%) were treated with culotte (culotte subgroup), 43 (6%) were treated with kissing (kissing subgroup) and 81 (12%) were treated with T stenting (T subgroup). Angiographic and clinical successes of PCI were obtained in all patients. During the in-hospital period, MACE occurred in 7 (0.8%) patients including 5 (0.6%) cardiac deaths and 2 (0.2%) MIs. one patient had definite (died) and four patients had probable stent thrombosis (1 had a MI and 3 died). During the long-term follow-up duration of 27±20 months, MACE occurred in 176 (22%) patients including 25 (3%) cardiac deaths, 16 (2%) MIs and 135 (17%) TLRs. six patients had probable (died) and 12 patients had possible stent thrombosis (2 had MI and 10 died). There were no significant differences in in-hospital MACE rates between nondistal and distal subgroup, between 1-stent and 2-stent subgroup and among different 2-stent technique subgroups. After long-term follow-up, the TLR rate was significantly higher in distal subgroup than in nondistal subgroup (18% vs 9%, p<0.05), the MACE rate was significantly higher in 2-stent subgroup than in 1-stent subgroup (28% vs 20%, p<0.05), and the different 2-stent technique subgroups showed similar long-term outcomes. The total stent thrombosis rates were also no significant differences between nondistal and distal subgroup, between 1-stent and 2-stent subgroup and among different 2-stent technique subgroups. Conclusions Treatment of ULM with DES is feasible and safe with good in-hospital and acceptable long-term clinical results. Compared with ostial and shaft lesion, distal bifurcation lesion is associated with a worse long-term TLR rate. 1-stent technique had a better long-term MACE rate than 2-stent technique when distal bifurcation lesion was treated, whereas different 2-stent techniques had similar clinical outcomes.

Initial and Long-Term Clinical Outcomes of Unprotected Left Main Stenting Using Drug Eluting Stents

Long-term Outcome Comparison of Ostial/shaft Lesions in Unprotected Left Main Coronary Artery Treated by PCI or CABG

[Long-Term Outcomes and Risk Factors of Ostial/shaft Lesions in Unprotected Left Main Coronary Artery after Percutaneous Coronary Intervention].

Prognosis Of Unprotected Left Main Coronary Artery Stenting And The Factors Affecting The Outcomes In Chinese

Long-Term Effects of Drug-Eluting Stents Versus Bare Metal Stents on Patients with Acute St-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Outcomes of 3-Year Clinical Follow-Up

DRUG-ELUTING STENTING VERSUS CORONARY ARTERY BYPASS GRAFT FOR UNPROTECTED LEFT MAIN CORONARY ARTERY DISEASE: A META-ANALYSIS BASED ON TIME-TO-EVENT DATA FROM RANDOMISED CONTROLLED TRIALS

Long-term Prognosis of Drug Eluting Stents Implantation in Elderly Patients with Unprotected Left Main Coronary Artery Disease

Clinical efficacy and follow up of drug eluting stent treatment for 120 unprotected left main coronary artery lesions

Comparison of the efficacy of drug-eluting stents versus bare-metal stents for the treatment of left main coronary artery disease.

Long-Term Clinical Outcomes of Unprotected Left Main Percutaneous Coronary Intervention: A Large Single-Centre Experience

Long-term Outcomes Following Drug-Eluting Stent Implantation in Unprotected Left Main Bifurcation Lesions.

Clinical Outcome after Management of Unprotected Left Main In-Stent Restenosis after Bare Metal or Drug-Eluting Stents

Short-medium term effects of drug eluting stent implantation in unprotected left main coronary artery disease

Comparison of Short- and Long-Term Clinical Outcomes of Drug-Eluting Stent Implantation Versus Coronary Artery Bypass Grafting in 121 Patients with Unprotected Left Main Coronary Artery Disease

Comparison of Drug-Eluting Stents with Bare Metal Stents Implantation for the Treatment of Acute ST-elevation Myocardial Infarction: 2-Year Clinical Outcomes from Single-Center Registry.

Long-term Efficacy and Safety of Drug-Eluting Stent Implantation for Patients with Multiple Coronary Chronic Total Occlusions.

Provisional Vs. Two-Stent Technique for Unprotected Left Main Coronary Artery Disease after Ten Years Follow Up: A Propensity Matched Analysis

Meta-analysis of long-term efficacy on the treatment of unprotected left main coronary artery ;disease

Mid-term treatment results of drug-eluting stent implantation for patients with multivessel chronic total coronary occlusion lesions

Drug-eluting Stents for Patients with Acute Coronary Syndromes: an Analysis of Long Term Outcome

Long term clinical effects of drug eluting stent in treating acute myocardial infarction